在东京,日本经济研究中心的一份报告中指出:“通过推进有关合资经营及技术合作计划,日本将超过美国,从而在21世纪的生物技术领域获得全世界的领先地位”。在华盛顿,美国议会的一份研究报告断言日本是“美国最强硬的竞争对手”,并强调指出,日本政府“已经把生物技术商品化当作一项国策”。日本的公司已经开始向美国第一流的公司提供专门的生产技术,这样的情况不断增加。 In Tokyo, a report of the Japan Center for Economic Research stated: “By advancing related joint ventures and technical cooperation programs, Japan will surpass the United States and thus gain a leading position in the world of biotechnology in the 21st century.” In Washington, a U.S. parliament’s research report asserted that Japan was “the strongest competitor in the United States” and emphasized that the Japanese government “has considered biotechnology commercialization as a national policy”. Japanese companies have begun to provide specialized production technology to top-tier companies in the United States, and this situation continues to increase.